Antibody to human interleukin-6 receptor
US5670373A · kind A · utility
187Cited by
1References
13Claims
0Family size
Inventor
Key dates
| Filing date | Dec 15, 1994 |
| Grant date | Sep 23, 1997 |
| Priority date | — |
| Expiry date | Dec 15, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies, polyclonal and monoclonal, which are capable of specifically binding to a human interleukin-6 receptor. Also included are monoclonal antibodies which competitively and non-competitively inhibit human interleukin-6, and a method of producing hybridomas of the said monoclonal antibodies capable of specifically binding to a human interleukin-6 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.